EQUATOR reporting guidelines should also be used by clinicians

EQUATOR: reporting guidelines for health research

Competing interests: We are all involved in health-care initiatives and research that should benefit from wide uptake of reporting guidelines. editors and peer reviewers, the quality of health-research reporting in journal articles is unsatisfactory. 1–6 Guidelines that specify a minimum set of items for reporting can improve the accuracy and transparency of publications, thus facilitating easi...

Should Priority Setting Also Be Concerned About Profound Socio-Economic Transformations? A Response to Recent Commentary

Omeprazole and clopidogrel: Should clinicians be worried?

The US Food and Drug Administration has issued a warning that omeprazole (Prilosec) reduces the antiplatelet activity of clopidogrel (Plavix) by about 50%. However, the warning is based largely on ex vivo data. Preliminary results from a randomized clinical trial revealed no effect on cardiovascular outcomes when omeprazole was given with clopidogrel. We recommend that physicians continue to pr...

Should levodopa be used anymore?

Levodopa is the most potent dopaminergic oral drug available in clinical practice. After chronic treatment, many patients with Parkinson's disease develop dyskinesia and motor fluctuations which are difficult to manage. It was hoped that introduction of dopaminergic agonists could diminish these side effects while keeping the same efficacy as levodopa. Prospective clinical data do not support t...

criticism sould have to be scaled also publication should have to be valid

0